Lori Anne Kunkel
Director at Enliven Therapeutics, Inc. (ELVN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $850K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 8SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 4,11147,773 held (−8%) | $49.98 | $205K | -18.0% |
| Jul 8SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 5,88941,884 held (−12%) | $50.84 | $299K | -19.4% |
| Jun 9SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 7,77954,105 held (−13%) | $34.28 | $267K | +19.5% |
| Jun 9SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 1,86752,238 held (−3%) | $35.36 | $66K | +15.9% |
| Jun 9SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 35451,884 held (−1%) | $35.82 | $13K | +14.4% |
- Sell
Director Lori Anne Kunkel sold $205K of ELVN at $49.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lori Anne Kunkel sold $299K of ELVN at $50.84 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lori Anne Kunkel sold $267K of ELVN at $34.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lori Anne Kunkel sold $66K of ELVN at $35.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lori Anne Kunkel sold $13K of ELVN at $35.82 — pre-scheduled 10b5-1 plan sale.